ACES to help test treatment for schizophrenia

A North Idaho mental health agency has been selected by Yale University to participate in a clinical trial to improve treatment outcomes and the quality of life for individuals with schizophrenia.

ACES Community Health Services, with offices in Post Falls and Coeur d'Alene, will represent 25 percent of Yale's clinical trial.

Other sites include four agencies in Connecticut and one additional site in Idaho.

Schizophrenia is a mental illness that usually strikes in late adolescence or early adulthood. Symptoms can include delusions, hallucinations, disorganized speech, decreased emotional expression and diminished cognitive functioning.

"Schizophrenia is a treatable brain disease that affects one in every 100 people. It impacts almost every aspect of a person's life, but with the right supports and treatment, recovery is possible," said ACES therapist, Laura Cartwright.

The study focuses on comprehensive services that look in depth at the disease, treatment medications, motivational interviewing and relapse prevention.

ACES provides services in Kootenai, Benewah and Shoshone counties.

Information: http://aces-id.com/